Wedge Capital Management L L P NC Takes $26.93 Million Position in Teleflex Incorporated $TFX

Wedge Capital Management L L P NC bought a new position in shares of Teleflex Incorporated (NYSE:TFXFree Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 220,082 shares of the medical technology company’s stock, valued at approximately $26,929,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of TFX. Brooklyn Investment Group grew its position in Teleflex by 258.6% in the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock valued at $29,000 after acquiring an additional 150 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. boosted its stake in shares of Teleflex by 242.9% in the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 153 shares during the period. True Wealth Design LLC grew its holdings in shares of Teleflex by 10,333.3% in the second quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock valued at $37,000 after purchasing an additional 310 shares in the last quarter. Parallel Advisors LLC grew its holdings in shares of Teleflex by 43.1% in the second quarter. Parallel Advisors LLC now owns 455 shares of the medical technology company’s stock valued at $54,000 after purchasing an additional 137 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. increased its stake in Teleflex by 30.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 556 shares of the medical technology company’s stock worth $77,000 after buying an additional 129 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have commented on TFX. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Tuesday, December 9th. Truist Financial increased their price objective on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research note on Thursday. Wall Street Zen cut Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a report on Monday, December 15th. Finally, Zacks Research cut Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. One analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average price target of $142.43.

Read Our Latest Research Report on Teleflex

Teleflex Stock Down 2.2%

Teleflex stock opened at $121.73 on Friday. The stock has a market cap of $5.38 billion, a PE ratio of -16.56, a P/E/G ratio of 1.45 and a beta of 0.95. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.57 and a quick ratio of 1.53. The stock’s fifty day moving average is $120.13 and its two-hundred day moving average is $121.03. Teleflex Incorporated has a 1-year low of $102.58 and a 1-year high of $185.94.

Teleflex (NYSE:TFXGet Free Report) last released its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, beating analysts’ consensus estimates of $3.38 by $0.29. The business had revenue of $892.90 million for the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The business’s revenue for the quarter was up 19.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. On average, sell-side analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. The ex-dividend date was Friday, November 14th. Teleflex’s payout ratio is currently -18.50%.

Teleflex Company Profile

(Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Featured Articles

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.